Press
If you would like to discuss anything press related, please email press@rarecan.com
RareCan in the news
10 January 2023 Meet the three North East firms to make list of top 100 UK innovators
November 2022 – 10 New Companies join data-driven health accelerator KQ Labs
UK Business Angels Association – 5 July 2022 – Newcastle – based Rare Cancer Research Start-Up RareCan Secures Six Figure Investment to Grow Business
Britain Daily – 30 June 2022 – House Music Pioneer and Star DJ Sasha to Play Intimate Gig to Help Dad Speed Up Research into Rare Cancers
Newcastle University – 28 June 2022 – Retired Professor sets up Business to Accelerate Rare Cancer Research
Innovation Super Network North East England – 27 June 2022 – Newcastle Based Rare Cancer Research Start Up Secures Six Figure Investment to Grow Business
Inside Media – 24 June 2022 – Medical Research Platform Smashes Crowdfunding Target
Business Live – 20 June 2022 – Female angel syndicate helps Northern founders raise almost £2.5m in first year
National Health Executive – 24 January 2022 – Digitalisation of Clinical Trials
Novopath – 9 December 2021 – Novopath & RareCan Research and Innovation Collaboration
Newcastle Chronicle – 25 November – Inside the Newcastle ‘BioBank’ of blood and tissue samples which could help cure rare cancers
Drug Discovery World – 23 November – Accelerating Research: The Path Forward for Treating Rare Cancers
Adlib Recruitment – 19th November – Product People Potential – Our Chat with RareCan Limited
weareumi – 10th November – Go Further Investment Index Celebrates most Progressive Northern UK Businesses
EPM Magazine – 9th November – Blood Cancer UK Partners with RareCan to Improve Delivery of Clinical Trials
Technology Networks – 9th November – RareCan Receives Approval from NHS Research Ethics Committee to Establish Vital BioResource at Newcastle University
Northern Echo – 4th November – Teesside University New Cancer Treatment Research Partnership
PharmaTimes – 2nd November 2021 – Putting Digitally Empowered Patients at the Core of Rare Cancer Research
Drug Discovery World – 26th October 2021 – RareCan Receives approval to establish BioResource at Newcastle University
Newcastle Chronicle – 5th October 2021 – Newcastle professor’s ‘matchmaking’ site helps patients with rare cancers find the clinical trials that could save their lives
Pharmafile – 25th August 2021 – RareCan appoints Dr Anita Cooper
Drug Discovery World – 4th August 2021 – Appointment strenghtens the experience of RareCanGMe

Mandashi Invests in RareCan
Mandashi Invests in RareCan We urgently need to increase treatment options and improve outcomes for people with rare cancer. At RareCan, we are working with

RareCan and NovoPath Partnership
NovoPath & RareCan Partnership Analysing samples from tumours lies at the heart of the discovery of new forms of treatment for cancer. Rare Cancers are

PAWS GIST & GIST Cancer UK Partnership
PAWS GIST & GIST Cancer UK Partnership A couple of weeks ago we announced our collaboration with PAWS GIST and GIST Cancer UK. This collaboration,